Evidence map›Paper›PMID 39998960›Full record

ReviewImmunity, inflammation and disease2025

Natural Resistance to HIV Infection: Role of Immune Activation.

María M Naranjo-Covo, Daniel S Rincón-Tabares, Lizdany Flórez-Álvarez, Juan C Hernandez, Wildeman Zapata-Builes

Erratum issuedAbstract readReview
In one paragraph

Review in Immunity, inflammation and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

María M Naranjo-CovoGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Daniel S Rincón-TabaresGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.ORCID 0000-0002-2614-3881
Lizdany Flórez-ÁlvarezDepartamento de Parasitología, Instituto de Ciencias Biomédicas, Universidad de Sao Paulo, Sao Paulo, Brazil.
Juan C HernandezGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.ORCID 0000-0002-9200-5698
Wildeman Zapata-BuilesGrupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.ORCID 0000-0002-7351-8738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough repeated exposure to HIV-1 can result in infection, some individuals remain seronegative without clinical or serologic evidence of infection; these individuals are known as HIV-1-exposed seronegative individuals. This population has been extensively studied to understand the mechanisms associated with natural resistance to HIV infection. Two main hypotheses have been proposed to explain this resistance: some researchers associated resistance with a low activation phenotype characterized by a decrease in the activation and proliferation of immune system cells linked with infection control and decreased production of cytokines and pro-inflammatory molecules, whereas others suggest that resistance is related to immune system activation and the expression of high levels of chemokines, pro-inflammatory cytokines and antiviral molecules.

aimsOur study aims to review and analyze the most relevant evidence supporting the role of the activation level of the immune system during natural resistance to HIV-1 infection.

methodsA search was conducted via the PubMed, SciELO and ScienceDirect databases. The literature search was performed in a nonsystematic manner. Articles published in the last five decades addressing immune activation mechanisms in natural resistance to HIV were reviewed.

resultsA low-activation phenotype, characterized by a high frequency of Treg cells; reduced expression of CD25, CD38, and HLA-DR; and lower production of pro-inflammatory cytokines in peripheral and mucosal tissues, plays a key role in reducing the number of activated cells susceptible to infection, but it minimizes chronic inflammation, facilitating viral entry and spread. In contrast, the activation phenotype is associated with high expression of markers such as CD25, CD38, and HLA-DR, along with elevated high levels of interferon-stimulated genes and pro-inflammatory cytokines. This profile could promote infection control while increasing the number of virus-susceptible cells.

conclusionThe complexity of the immune response during HIV exposure, reflected in the conflicting evidence concerning whether low or high immune activation offers protection against infection, suggests that there may be multiple pathways to HIV-1 resistance, influenced by factors such as the type of viral exposure, the immune environment, and individual genetics. Further research is needed to determine which immune states are protective and how these responses can be modulated to prevent infection.

Indexed as

HIV InfectionsImmunity, InnateADP-ribosyl Cyclase 1HIV SeronegativityHLA-DR AntigensHumansInterleukin-2 Receptor alpha SubunitMembrane GlycoproteinsADP-ribosyl Cyclase 1CD38 protein, humanHLA-DR AntigensIL2RA protein, humanInterleukin-2 Receptor alpha SubunitMembrane GlycoproteinsHESNHIV‐1immune activationnatural resistance

Identifiers

PMID39998960
PMCPMC11854356

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.